Gender based Prediction Equation to assess Aerobic Capacity in Chronic Obstructive Pulmonary Disease patients with Infection
收藏Mendeley Data2026-04-18 收录
下载链接:
https://data.mendeley.com/datasets/59zt6xr999
下载链接
链接失效反馈官方服务:
资源简介:
This study investigates the prognostic role of functional assessment in chronic obstructive pulmonary disease (COPD) patients with infection, emphasizing the six-minute walk test (6MWT) as a practical substitute for cardiopulmonary exercise testing (CPET). The 6MWT is simple, inexpensive, and safer for patients unable to perform CPET, making it valuable in low-resource settings. While reduced six-minute walk distance (6MWD) is linked with COPD severity, its role in predicting infection-related exacerbations remains underexplored.
COPD is a progressive, irreversible disease marked by airflow limitation and frequent infections. It causes reduced lung function, exercise intolerance, and poor quality of life. Smoking is the main cause, though pollution, occupational exposures, and genetics also contribute. Exacerbations worsen prognosis and strain healthcare systems, especially where diagnostic tools are limited.
In this study, 80 clinically stable patients with infection-related exacerbations were evaluated using spirometry and the 6MWT. Peak oxygen uptake (VO₂ max) was estimated from walking distance. Demographic variables, body mass index, and symptom burden (mMRC and Borg scales) were recorded. Data were analyzed with non-parametric statistics and regression models.
The cohort was mostly middle-aged, with severe airflow limitation and a slight male predominance. Emphysema was the most common phenotype. The 6MWT revealed clear exertional limitation, with Borg scores indicating breathlessness. Walking distance strongly correlated with VO₂ max (r² > 0.95) and FEV₁/FVC (r = 0.731, p < 0.001). Gender explained most variance in VO₂ max, reflecting physiological differences in lung function and muscle mass. Both low and high BMI negatively affected performance, suggesting a U-shaped link between body composition and exercise capacity.
Clinically, results emphasize the complementary role of functional testing with spirometry. The 6MWT is reproducible, requires minimal infrastructure, and is ideal where CPET is unavailable. Gender-specific predictive equations developed in this study support individualized rehabilitation and safer exercise prescriptions. Embedding such models into digital platforms could extend monitoring to community and home care.
In conclusion, integrating 6MWT with spirometry provides a reliable, field-friendly approach for predicting aerobic capacity and managing infection-related exacerbations in COPD. This combined strategy supports personalized care, especially in resource-limited settings, and has potential to improve patient outcomes while reducing disease burden.
本研究探讨了功能评估在合并感染的慢性阻塞性肺疾病(chronic obstructive pulmonary disease, COPD)患者中的预后价值,重点关注六分钟步行试验(six-minute walk test, 6MWT)作为心肺运动试验(cardiopulmonary exercise testing, CPET)的实用替代方案。6MWT操作简便、成本低廉,且对于无法完成CPET的患者更为安全,因此在资源受限地区(resource-limited settings)具有重要应用价值。尽管六分钟步行距离(six-minute walk distance, 6MWD)缩短与COPD病情严重程度相关,但其在预测感染相关急性加重中的作用仍未得到充分探索。
COPD是一种进行性、不可逆的疾病,以气流受限和反复感染为主要特征,可导致肺功能下降、运动耐量受损及生活质量降低。吸烟是其主要致病因素,空气污染、职业暴露及遗传因素也可参与发病。急性加重会恶化患者预后,加重医疗系统负担,在诊断工具匮乏的地区尤为明显。
本研究对80例临床稳定的感染相关COPD急性加重患者进行了肺量测定法(spirometry)及6MWT评估。通过步行距离估算峰值摄氧量(peak oxygen uptake, VO₂ max),并记录了人口学变量、体质量指数(body mass index, BMI),以及采用改良英国医学研究委员会呼吸困难量表(modified Medical Research Council, mMRC)与博格量表(Borg scales)评估的症状负荷。数据采用非参数统计(non-parametric statistics)及回归模型(regression models)进行分析。
该队列患者以中年人群为主,多数存在重度气流受限,男性占比略高。肺气肿(emphysema)是最常见的表型(phenotype)。6MWT结果显示患者存在明确的运动耐量受限,博格量表评分提示存在呼吸困难。步行距离与VO₂ max(r²>0.95)及FEV₁/FVC(一秒用力呼气容积/用力肺活量,r=0.731, p<0.001)均呈强相关性。性别可解释VO₂ max的大部分变异,这反映了肺功能与肌肉量的生理差异。体质量指数过高或过低均会对运动表现产生负面影响,提示身体成分与运动能力之间存在U型关联。
从临床角度而言,本研究结果凸显了功能检测与肺量测定法的互补作用。6MWT可重复、所需基础设施极少,是CPET不可及场景下的理想检测手段。本研究开发的性别特异性预测方程可为个体化康复及更安全的运动处方提供支持。将此类模型嵌入数字平台,可将监测范围拓展至社区与居家照护场景。
综上,将6MWT与肺量测定法相结合,可为COPD合并感染患者的有氧能力(aerobic capacity)预测及感染相关急性加重管理提供一种可靠、便于现场实施的方案。该联合策略可支持个体化照护,尤其适用于资源受限地区,有望在改善患者预后的同时降低疾病负担。
创建时间:
2025-08-26



